ProSolv CardioVascular

 
 ProSolv CardioVascular version 4.0
ProSolv CardioVascular, (2049), a Fujifilm company, is highlighting version 4.0 of its ProSolv CardioVascular. The new release features ProSolv as a web-based application for full viewing and reporting capabilities using web communication protocols, secured via SSL, in addition to a web URL single-click application download and installation. Numerous viewing and reporting enhancements are also included for cardiac catheterization, echocardiography, vascular ultrasound and nuclear cardiology, in addition to the introduction of an Accreditation Toolkit for ease of statistical reporting to the Intersocietal Accreditation Commission. 

This new release will include the integration of Fujifilm’s radiology PACS application, Synapse, with ProSolv CardioVascular Image and Information System (CVIIS). The integration will give ProSolv users access to all Synapse radiology data from one workstation, with a single sign-on and user interface. Conversely, it will allow Synapse users to access ProSolv’s industry leading CVIIS within the Synapse application. The benefits of the integration range from both workflow and clinical advantages for users – administrative and clinical – to shared infrastructure for the facility. Additionally, ProSolv users can benefit from Fujifilm’s patented technologies, such as AON compression and CommonView for a view of all imaging data.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.